SCHEMBL24065299

SCHEMBL24065299

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-n5c6ccccc6c6ccc(-c7ccccc7)cc65)cc4)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ HDAC4 P56524 1/20 0.41
▸ AVPR1A P37288 1/20 0.41
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ RXRA P19793 2/20 0.38
▸ RXRB P28702 1/20 0.38
▸ OXTR P30559 1/20 0.38
▸ NR3C1 P04150 1/20 0.37
▸ PTPN1 P18031 1/20 0.36
▸ IL1R1 P14778 1/20 0.36
▸ F2 P00734 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20291222 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL14749020 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL22386906 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL21472401 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL14748968 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL23263473 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL21472258 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL24361775 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL22386989 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A
SCHEMBL12092940 1.00 ATM (0.50) ATML3MBTL1KDM4EHDAC4AVPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024144176-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY APPARATUS 삼성에스디아이 주식회사 2024-07-04 — — WO disclosed
WO-2024128697-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE 삼성에스디아이 주식회사 2024-06-20 — — WO disclosed
US-20230292537-A1 LIGHT EMITTING DEVICE THAT EMITS GREEN LIGHT, AND LIGHT EMITTING SUBSTRATE AND LIGHT EMITTING APPARATUS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-09-14 — — US disclosed
US-20230292537-A1 LIGHT EMITTING DEVICE THAT EMITS GREEN LIGHT, AND LIGHT EMITTING SUBSTRATE AND LIGHT EMITTING APPARATUS BOE TECHNOLOGY GROUP CO., LTD. (CN) 2023-09-14 — — US disclosed
US-20230119201-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC ELEMENT, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2023-04-20 — — US disclosed
US-20220006029-A1 COMPOSITION FOR OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2022-01-06 — — US disclosed
US-20210380534-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-12-09 — — US disclosed
US-20210376245-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210380534-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OCIAD2, OSTC ATM 4228/4885L3MBTL1 4863/4885KDM4E 4451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback